Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -201,142 | -195,882 | -198,133 | -121,821 | -165,367 |
| Depreciation Amortization | 5,384 | 3,034 | 1,245 | 1,974 | 1,283 |
| Income taxes - deferred | N/A | N/A | -279 | -964 | -624 |
| Accounts payable and accrued liabilities | 996 | -5,257 | 9,140 | 2,458 | 1,185 |
| Other Working Capital | -5,340 | 31,076 | 2,647 | -35,401 | 31,176 |
| Other Operating Activity | 37,538 | 44,164 | 19,968 | 21,927 | 98,265 |
| Operating Cash Flow | $-162,564 | $-122,865 | $-165,412 | $-131,827 | $-34,082 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -104,232 | 74,751 | 27,605 | -30,336 | -68,980 |
| PPE Investments | -4,531 | -7,294 | -8,724 | -16,095 | -4,150 |
| Other Investing Activity | 0 | 1,000 | -170 | -665 | -496 |
| Investing Cash Flow | $-108,763 | $68,457 | $18,711 | $-47,096 | $-73,626 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 139,512 | 189,876 | 655 | 185,536 | N/A |
| Other Financing Activity | 12,000 | 6,000 | 0 | -4,042 | 269,278 |
| Financing Cash Flow | $151,512 | $195,876 | $655 | $181,494 | $269,278 |
| Beginning Cash Position | 196,538 | 55,070 | 201,116 | 198,545 | 36,975 |
| End Cash Position | 76,723 | 196,538 | 55,070 | 201,116 | 198,545 |
| Net Cash Flow | $-119,815 | $141,468 | $-146,046 | $2,571 | $161,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -162,564 | -122,865 | -165,412 | -131,827 | -34,082 |
| Capital Expenditure | -4,531 | -7,294 | -8,724 | -16,095 | -4,150 |
| Free Cash Flow | -167,095 | -130,159 | -174,136 | -147,922 | -38,232 |